Adaptive Biotechnologies Corporation
ADPT · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $277M | $179M | +54.8% |
| Operating income | −$57.1M | −$163M | +64.9% |
| Net income | −$59.5M | −$159M | +62.7% |
Latest quarter: Q3 2026
Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 4, 2026
| $ | Q3 2026 | Year earlier | Change |
|---|---|---|---|
| Revenue | $83.9M | $94.0M | −10.7% |
| Operating income | −$500K | $10.3M | |
| Net income | $2.90M | $9.50M | −69.5% |
Q3 2026 dashboardQ3 2026 infographic
Questions
- What was Adaptive's revenue in FY2025?
- $277M in FY2025 (Fiscal year ended Dec 31, 2025), +54.8% vs $179M a year earlier, per its 10-K filed Feb 2026.
- Was Adaptive profitable in FY2025?
- No: net income was −$59.5M and operating income −$57.1M in FY2025.
- What was Adaptive's revenue in Q3 2026?
- $83.9M (−10.7% vs a year earlier), per its Form 10-Q filed Nov 4, 2026.